Northwest Biotherapeutics (NWBO) Intangibles (2020 - 2026)

Northwest Biotherapeutics' Intangibles history runs 7 years deep, the most recent figure standing at $52.0 million for Q1 2026.

• On a quarterly basis, Intangibles rose 3928.48% year-over-year to $52.0 million in Q1 2026; TTM through Mar 2026 was $52.0 million, a 3928.48% increase from a year earlier, with the FY2025 full-year figure at $53.2 million, up 4016.72% from the prior year.
• Intangibles declined to $52.0 million in Q1 2026 per NWBO's latest filing, from $53.2 million in the prior quarter.
• Across five years, Intangibles topped out at $53.2 million in Q4 2025 and bottomed at $1.3 million in Q1 2022.
• The 5-year median for Intangibles is $1.3 million (2022), against an average of $7.3 million.
• Across the five-year window, Intangibles changed 0.0% in 2022 and surged 4016.72% in 2025, its largest moves.
• Year by year, Intangibles stood at $1.3 million in 2022, then changed by 0.0% to $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024, then jumped by 4016.72% to $53.2 million in 2025, then fell by 2.14% to $52.0 million in 2026.
• Per Business Quant, the three latest NWBO Intangibles figures stand at $52.0 million (Q1 2026), $53.2 million (Q4 2025), and $1.3 million (Q3 2025).